Chart's Investor Day Reaffirms Our Conviction in Its Multiple Tailwinds
Three-year targets introduced at Chart’s 2023 analyst day included a 17%-plus annual revenue growth, 25%-plus annual EPS growth, and margin expansion of 300-600 basis points. We expect management will ...
Anavex, Cassava Sciences, Panax Ginseng, And The Long-Term Treatment Of Alzheimer's Disease
Panax ginseng shows highest effectiveness in treating Alzheimer's. Learn more about AVXL's blarcamesine and SAVA's simufilam ...